MedPath

Promoting Early Adolescent Non-smoking With a Game Intervention Supporting Self-efficacy

Not Applicable
Completed
Conditions
Self Efficacy
Smoking
Interventions
Behavioral: Game intervention
Registration Number
NCT05290103
Lead Sponsor
University of Turku
Brief Summary

This intervention study evaluates the effectiveness of a digital game intervention supporting smoking refusal self-efficacy among early adolescents (10-13 y). The participants are randomly allocated to two groups: the experimental group that receives the digital game intervention, and the control group that receives no intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
781
Inclusion Criteria
  • Goes to school at 4th, 5th, or 6th grade
  • Sufficient skills in Finnish or Swedish
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Game interventionGame interventionParticipants in this arm will receive the game intervention including 15-30 minutes of digital health game playing at school and 2 weeks of free usage of the game during free time and a 30-minute debriefing session with a researcher.
Primary Outcome Measures
NameTimeMethod
Change in smoking refusal self-efficacyAt baseline, at 2 weeks, and at 3 months

Assessed with a smoking refusal self-efficacy scale (scores 6-24; higher scores indicate stronger smoking refusal self-efficacy).

Secondary Outcome Measures
NameTimeMethod
Change in sources of refusal self-efficacy related to tobacco useAt baseline, at 2 weeks, and at 3 months

Subscales for cigarette use (7 items) and snus use (7 items). Both are assessed with a 4-point Likert-scale questionnaire.

Change in motivation to decline tobacco use in the futureAt baseline, at 2 weeks, and at 3 months

Subscales for cigarette use and snus use. Both are assessed with a 4-point Likert-scale questionnaire (scores 1-4, lower scores indicate stonger motivation to decline tobacco use in future).

Trial Locations

Locations (1)

Primary schools (n=15)

🇫🇮

Nine Cities, Finland

© Copyright 2025. All Rights Reserved by MedPath